ConductScience.org, home

Gene · 1032

CDKN2D: cyclin dependent kinase inhibitor 2D

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CDKN2D: cyclin dependent kinase inhibitor 2D. Genes, record 1032. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1032

On this page

Gene

Symbol
CDKN2D
HGNC
Name
cyclin dependent kinase inhibitor 2D
HGNC
NCBI Gene ID
1032
NCBI Gene
HGNC ID
HGNC:1790
HGNC
Ensembl
ENSG00000129355
NCBI Gene
Aliases
INK4D, p19, p19-INK4D
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P55273Cyclin-dependent kinase 4 inhibitor D1662Ensembl, GeneID, HGNC

Source UniProt

Patents43

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4641202 A22025-10-295093P55273Espacenet
KR 1020250017231 A2025-02-045093P55273Espacenet
EP 4484957 A12025-01-0170P55273Espacenet
US 12130290 B22024-10-296P55273Espacenet
JP 2024123008 A2024-09-105821P55273Espacenet
JP 2024123008 A2024-09-105822P55273Espacenet
WO 2023162878 A2023-08-3170P55273Espacenet
US 11446398 B22022-09-2021385P55273Espacenet
US 11446398 B22022-09-2021386P55273Espacenet
JP 2022524081 A2022-04-27124356P55273Espacenet

1 to 10 of 43

See all 43 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,110

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCDKN2D papersNewest fiscal year
P30CA021765Cancer Center Support Grant (CCSG)112025
P30CA016672Cancer Center Support Grant62025
P30CA016056Roswell Park Cancer Center Support Grant52025
P30CA015083Mayo Clinic Comprehensive Cancer Center Support Grant42025
P01CA100730Retrovirus Models of Cancer32025
P30AG066546South Texas Alzheimer's Disease Center32025
P30CA008748Cancer Center Support Grant32025
P30CA016042Cancer Center Support Grant32025
P30CA016058Cancer Center Support Grant32025
P30CA047904Cancer Center Support Grant32025

1 to 10 of 1,110Source NIH's project files

See all 1,110 nih grants

Papers1,704

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Sex-specific associations of the plasma proteome with incident coronary artery disease.Cardiovasc Res202642687758PubTator, text miningPubMed
NOR1 loss relates to inflammation and biological ageing in multiple sclerosis motor cortex.Brain Commun202642661990PubTator, text miningPubMed
CRISPR/Cas9-Mediated Gene Knockout Reveals a Nonredundant Role for p16INK4A in Controlling TCR-Dependent and Independent CD8 T Cell Expansion.Eur J Immunol202642345443PubTator, text miningPubMed
Defective efferocytosis links autonomic dysfunction and atrial fibrillation: multi-omics integration and in vivo validation.Front Immunol202642254027PubTator, text miningPubMed
RNA N6-methyladenosine (m6A) regulates cell cycle progression in diffuse midline glioma (DMG) and confers sensitivity to FTO inhibition.Cell Death Dis202641888518PubTator, text miningPubMed
Paired-Box (PAX) Gene Signatures as a Biomarker of Breast Cancer Progression.Int J Mol Sci202641752124PubTator, text miningPubMed
Characterizing the SASP-Dependent Paracrine Spreading of Senescence Between Human Brain Cell Types.bioRxiv202641726875PubTator, text miningPubMed
Mathematical analysis of G1/S sub-networks in hematopoietic proliferation: Sequential and lineage-specific activation.iScience202641717016PubTator, text miningPubMed
Tumor cell cycle regulation: integrated perspective of stage characteristics, regulatory networks, and signaling pathway intervention strategies.Mol Biomed202641692895PubTator, text miningPubMed
Transthyretin Amyloid May Drive Fibrosis and Proliferation of Tenosynovial Fibroblasts in Carpal Tunnel Syndrome.J Bone Joint Surg Am202641678652PubTator, text miningPubMed

1 to 10 of 1,704

See all 1,704 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/1032

GET https://conductscience.org/api/genes/v1/1032/patents?page=2